Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Social exclusion leads to divergent changes of oxytocin levels in borderline patients and healthy subjects.

Jobst A, Albert A, Bauriedl-Schmidt C, Mauer MC, Renneberg B, Buchheim A, Sabass L, Falkai P, Zill P, Padberg F.

Psychother Psychosom. 2014;83(4):252-4. doi: 10.1159/000358526. Epub 2014 Jun 24. No abstract available.

PMID:
24969030
2.

Reduced plasma oxytocin levels in female patients with borderline personality disorder.

Bertsch K, Schmidinger I, Neumann ID, Herpertz SC.

Horm Behav. 2013 Mar;63(3):424-9. doi: 10.1016/j.yhbeh.2012.11.013. Epub 2012 Nov 29.

PMID:
23201337
3.

Effects of social exclusion on emotions and oxytocin and cortisol levels in patients with chronic depression.

Jobst A, Sabass L, Palagyi A, Bauriedl-Schmidt C, Mauer MC, Sarubin N, Buchheim A, Renneberg B, Falkai P, Zill P, Padberg F.

J Psychiatr Res. 2015 Jan;60:170-7. doi: 10.1016/j.jpsychires.2014.11.001. Epub 2014 Nov 10.

PMID:
25466833
4.

Medial prefrontal cortex hyperactivation during social exclusion in borderline personality disorder.

Ruocco AC, Medaglia JD, Tinker JR, Ayaz H, Forman EM, Newman CF, Williams JM, Hillary FG, Platek SM, Onaral B, Chute DL.

Psychiatry Res. 2010 Mar 30;181(3):233-6. doi: 10.1016/j.pscychresns.2009.12.001. Epub 2010 Feb 12.

PMID:
20153143
5.

Neuroendocrine evaluation of depression in borderline patients.

Carroll BJ, Greden JF, Feinberg M, Lohr N, James NM, Steiner M, Haskett RF, Albala AA, DeVigne JP, Tarika J.

Psychiatr Clin North Am. 1981 Apr;4(1):89-99. No abstract available.

PMID:
7232239
6.

Facial emotional expression in reaction to social exclusion in borderline personality disorder.

Staebler K, Renneberg B, Stopsack M, Fiedler P, Weiler M, Roepke S.

Psychol Med. 2011 Sep;41(9):1929-38. doi: 10.1017/S0033291711000080. Epub 2011 Feb 9.

PMID:
21306661
7.

Oxytocin administration attenuates stress reactivity in borderline personality disorder: a pilot study.

Simeon D, Bartz J, Hamilton H, Crystal S, Braun A, Ketay S, Hollander E.

Psychoneuroendocrinology. 2011 Oct;36(9):1418-21. doi: 10.1016/j.psyneuen.2011.03.013. Epub 2011 May 4.

PMID:
21546164
8.

Human-lamb bonding: oxytocin, cortisol and behavioural responses of lambs to human contacts and social separation.

Coulon M, Nowak R, Andanson S, Ravel C, Marnet PG, Boissy A, Boivin X.

Psychoneuroendocrinology. 2013 Apr;38(4):499-508. doi: 10.1016/j.psyneuen.2012.07.008. Epub 2012 Aug 9.

PMID:
22884274
9.

Social synchrony and oxytocin: from behavior to genes to therapeutics.

Hollander E.

Am J Psychiatry. 2013 Oct;170(10):1086-9. doi: 10.1176/appi.ajp.2013.13070848. No abstract available.

PMID:
24084810
10.

The effect of ostracism upon mood in youth with borderline personality disorder.

Lawrence KA, Chanen AM, Allen JS.

J Pers Disord. 2011 Oct;25(5):702-14. doi: 10.1521/pedi.2011.25.5.702.

PMID:
22023305
11.

Journal Watch review of oxytocin and reduction of social threat hypersensitivity in women with borderline personality disorder.

Jain S.

J Am Psychoanal Assoc. 2014 Aug;62(4):710-3. doi: 10.1177/0003065114543186. No abstract available.

PMID:
25135213
12.

Oxytocin can hinder trust and cooperation in borderline personality disorder.

Bartz J, Simeon D, Hamilton H, Kim S, Crystal S, Braun A, Vicens V, Hollander E.

Soc Cogn Affect Neurosci. 2011 Oct;6(5):556-63. doi: 10.1093/scan/nsq085. Epub 2010 Nov 29.

13.

Dexamethasone suppression test in borderline personality disorder--effects of posttraumatic stress disorder.

Lange W, Wulff H, Berea C, Beblo T, Saavedra AS, Mensebach C, Wingenfeld K, Driessen M.

Psychoneuroendocrinology. 2005 Oct;30(9):919-23.

PMID:
15896918
14.

The dexamethasone suppression test in borderline personality disorder.

Krishnan KR, Davidson JR, Rayasam K, Shope F.

Biol Psychiatry. 1984 Jul;19(7):1149-53. No abstract available.

PMID:
6477995
15.

Dexamethasone suppression test in borderline personality disorder: impact of PTSD symptoms.

Wingenfeld K, Hill A, Adam B, Driessen M.

Psychiatry Clin Neurosci. 2007 Dec;61(6):681-3.

16.

[New diagnostic and neuroendocrine approaches to the borderline syndrome].

Castro P, Pardoen D, Toscano-Aguilar M, Mendlewicz J.

Encephale. 1986 Jan-Feb;12(1):27-30. French.

PMID:
3698888
17.

[Experience of solitude in borderline personality psychopathology].

Scharbach H.

Ann Med Psychol (Paris). 1992 Apr-May;150(4-5):301-6. French. No abstract available.

PMID:
1343539
18.

Intranasal oxytocin administration attenuates the ACTH stress response in monkeys.

Parker KJ, Buckmaster CL, Schatzberg AF, Lyons DM.

Psychoneuroendocrinology. 2005 Oct;30(9):924-9.

PMID:
15946803
19.

Dexamethasone suppression test in hospitalized depressed patients with borderline personality disorder.

Beeber AR, Kline MD, Pies RW, Manring JM Jr.

J Nerv Ment Dis. 1984 May;172(5):301-3.

PMID:
6716096
20.

[Borderline personality disorder and transsexualism].

Seikowski K, Gollek S, Harth W, Reinhardt M.

Psychiatr Prax. 2008 Apr;35(3):135-41. Epub 2007 Aug 2. German.

PMID:
17671917

Supplemental Content

Support Center